P499: APPLICABILITY OF 2022 CLASSIFICATIONS OF ACUTE MYELOID LEUKEMIA IN THE REAL-WORLD SETTING

• Enrico Attardi,
• Arianna Savi,
• Beatrice Borsellino,
• Alfonso Piciocchi,
• Marta Cipriani,
• Tiziana Ottone,
• Emiliano Fabiani,
• Mariadomenica Divona,
• Serena Travaglini,
• Maria Rosaria Pascale,
• Arda Durmaz,
• Valeria Visconte,
• Matteo Giovanni Della Porta,
• Adriano Venditti,
• Jaroslaw P Maciejewski,
• Carmelo Gurnari,
• Maria Teresa Voso

Affiliations

Enrico Attardi

1 University of Rome Tor Vergata, Department of Biomedicine and Prevention, Rome, Italy

Arianna Savi

1 University of Rome Tor Vergata, Department of Biomedicine and Prevention, Rome, Italy

Beatrice Borsellino

1 University of Rome Tor Vergata, Department of Biomedicine and Prevention, Rome, Italy

Alfonso Piciocchi

2 Italian Group for Adult Hematologic Diseases (GIMEMA) Foundation, Rome, Italy

Marta Cipriani

3 Italian Group for Adult Hematologic Diseases (GIMEMA) Foundation, Rome, Italy

Tiziana Ottone

1 University of Rome Tor Vergata, Department of Biomedicine and Prevention, Rome, Italy

Emiliano Fabiani

1 University of Rome Tor Vergata, Department of Biomedicine and Prevention, Rome, Italy

Mariadomenica Divona

1 University of Rome Tor Vergata, Department of Biomedicine and Prevention, Rome, Italy

Serena Travaglini

1 University of Rome Tor Vergata, Department of Biomedicine and Prevention, Rome, Italy

Maria Rosaria Pascale

1 University of Rome Tor Vergata, Department of Biomedicine and Prevention, Rome, Italy

Arda Durmaz

7 Taussig Cancer Center, Cleveland Clinic, Translational Hematology and Oncology Research Department, Cleveland, United States

Valeria Visconte

7 Taussig Cancer Center, Cleveland Clinic, Translational Hematology and Oncology Research Department, Cleveland, United States

Matteo Giovanni Della Porta

8 Humanitas University, IRCCS Humanitas Clinical & Research Center and Department of Biomedical Sciences, Milan, Italy

Adriano Venditti

1 University of Rome Tor Vergata, Department of Biomedicine and Prevention, Rome, Italy

Jaroslaw P Maciejewski

7 Taussig Cancer Center, Cleveland Clinic, Translational Hematology and Oncology Research Department, Cleveland, United States

Carmelo Gurnari

1 University of Rome Tor Vergata, Department of Biomedicine and Prevention, Rome, Italy

Maria Teresa Voso

1 University of Rome Tor Vergata, Department of Biomedicine and Prevention, Rome, Italy